ArticleProceedings (Baylor University. Medical Center)2026
Secondhand smoke exposure and resting heart rate in young US adults: analysis of NHANES 2013-2018.
Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tracking the dangers of secondhand smoke.Proceedings (Baylor University. Medical Center) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Secondhand smoke (SHS) is a major cardiovascular risk factor, but its relationship with resting tachycardia, a marker of autonomic imbalance and adverse prognosis, remains unclear in young adults. Methods: We analyzed adults aged 18 to 40 years from the 2013-2018 National Health and Nutrition Examination Survey (NHANES). SHS exposure was defined as cotinine 0.05 to <10 ng/mL versus none (<0.05 ng/mL). The primary outcome was resting tachycardia ≥90 beats per minute (bpm) from standardized pulse measures; ≥100 bpm was examined in sensitivity analyses. Survey-weighted logistic regression estimated odds ratios (ORs) with sequential adjustment for clinical covariates. Results: The analytic sample included 4080 adults aged 18 to 40 years (representing ≈61.1 million US adults). Tachycardia prevalence was 9.98% (95% confidence interval [CI], 8.48-11.48) without detectable SHS and 9.05% (95% CI, 6.61-11.49) with SHS. SHS was not associated with tachycardia in unadjusted (OR 1.06, 95% CI 0.78-1.44), demographic-adjusted (OR 1.00, 95% CI 0.73-1.38), or fully adjusted models (OR 0.89, 95% CI 0.63-1.27), with consistent findings across age, sex, and race/ethnicity subgroups. In sensitivity analyses modeling cotinine continuously using restricted cubic splines within the detectable range (0.05-<10 ng/mL; n = 1382), there was no evidence of nonlinearity ( Conclusions: Among US adults aged 18 to 40, SHS exposure was not associated with resting tachycardia, although its broader cardiovascular risks remain substantial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.